XML 53 R35.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 12 Months Ended
Oct. 29, 2024
Mar. 25, 2024
Feb. 12, 2024
Jan. 08, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued for cash         2,806,311    
Purchase of shares 1,948,295            
Common stock, par value         $ 0.0001 $ 0.0001  
Gross proceeds $ 1,900,000            
Number of options outstanding         1,953,491    
Number of options outstanding         1,953,491 1,357,466  
Share based compensation weighted average exercise price         $ 5.36    
Share based compensation intrinsic value         $ 0    
Options to purchase common stock         742,150    
Options vested shares         233,324    
Share based compensation expense         $ 0 $ 0  
Employees [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Share based compensation expense         186,031 6,852  
Non-Employees [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Share based compensation expense         737,108 $ 659,976  
Unamortized stock option expense         $ 482,369    
Share-Based Payment Arrangement, Option [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of options issued         742,150 0  
Number of options outstanding         1,953,491 1,357,466  
Share based compensation weighted average exercise price         $ 5.36 $ 7.39  
Share based compensation expense         $ 923,139 $ 666,828  
Unamortized stock option expense         $ 1,012,825    
Weighted average period for unamortized stock compensation (in years)         2 years 9 months 29 days    
Options to purchase common stock         742,150    
Options exercise price         $ 1.73    
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Share based compensation expense         $ 431,884 206,104  
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Share based compensation expense         491,255 $ 460,724  
Employees [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Unamortized stock option expense         $ 530,456    
2016 Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of additional shares granted         196,857 186,594 184,260
Number of shares available for grant         873,763 1,279,181  
Series A Common Stock Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 1,948,295            
Exercise price of warrants $ 0.64            
Series B Common Stock Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 1,948,295            
Exercise price of warrants $ 0.64            
Term 5 years            
Exercise price $ 0.64            
Share price $ 0.89            
Series A Common Stock Purchase Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 1,948,295            
Series B Common Stock Purchase Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 1,948,295            
Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 1,948,295            
Common Stock [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of shares issued for cash         858,016    
Shares conversion           104,173  
Rounding of shares related to a reverse stock split           9,644  
Common Stock [Member] | Consulting Agreement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Options to purchase common stock     4,400        
Options expire period     10 years        
Options vest period     3 months        
Monthly payment     $ 5,000        
Options exercise price     $ 5.00        
Common Stock [Member] | Employees and Consultants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Options to purchase common stock       20,750      
Options exercise price       $ 0.84      
Options expire period       10 years      
Options vest period       48 months      
Common Stock [Member] | Officers, Board of Directors and Consultants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Options to purchase common stock   717,000          
Options exercise price   $ 1.74          
Options expire period   10 years          
Options vested shares   160,000          
Common Stock [Member] | Officers, Board of Directors and Consultants [Member] | Minimum [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Options vest period   24 months          
Common Stock [Member] | Officers, Board of Directors and Consultants [Member] | Maximum [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Options vest period   48 months          
Common Stock [Member] | Private Placement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock, par value $ 0.0001            
Placement Agent Warrants [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Purchase of shares 129,489            
Exercise price of warrants $ 0.64            
Purchase of shares of common stock 129,489            
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Shares issuable under warrants         4,968,645    
Warrant exercise price         $ 4.21    
Class of warrant or right, outstanding, intrinsic value         $ 0